Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
REE Automotive Continues to Expand Full by-Wire EV Offering at ACT Expo 2024
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Plug
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Luna
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Innoviz
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Evolv
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
-
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Chemours
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
-
Kymera Therapeutics to Participate in Upcoming May Investor Conferences
-
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
-
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
1stDibs Reports First Quarter 2024 Financial Results
-
More Than 90% of Metro Areas Recorded Home Price Increases in First Quarter of 2024
-
Kojamo plc Interim Report 1 January–31 March 2024
-
Immunocore reports first quarter financial results and provides a business update
-
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
-
MIND CTI Reports First Quarter 2024 Results
-
AvidXchange Announces First Quarter 2024 Financial Results
-
Brookfield Asset Management Announces Strong First Quarter Results
-
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
-
Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day
-
Temenos Multifonds extends partnership with Citi Securities Services to consolidate global funds services on Multifonds SaaS
-
Ducommun Incorporated Reports First Quarter 2024 Results
-
Azimut and SOQUEM Cut Very High Grade Lithium Drill Intercepts on Galinée, James Bay Region, Quebec
-
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
-
Kraken Robotics Receives $3.5 Million of Orders for Subsea Security Equipment
-
Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
-
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder
-
Form 8.3 - Tyman plc
-
Vow ASA: Vow receives payment for Early Production Line at VGM’s Hønefoss plant
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Parsons Receives Innovation Transportation Solutions Award from WTS Colorado
-
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc
-
Man Group PLC : Form 8.3 - Tyman plc
-
Initiated selection of an independent member of AB “Ignitis grupė” Supervisory Board
-
Taboola Q1 2024 Results Beat High End of Guidance; Reiterates 2024 Guidance and Expects Accelerating Growth Across All Key Metrics
-
Ingredion Completes Reorganization, Reports First Quarter Earnings Under New Segments and Raises Guidance
-
Qifu Technology to Hold Annual General Meeting on June 27, 2024
-
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
-
Radware Reports First Quarter 2024 Financial Results
-
Bunzl For Better: Canada’s New National Sustainability Initiative
-
It's time for Canada to deliver the promise of immigration
-
Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
-
Webuy to Present at the Emerging Growth Conference on May 9, 2024
-
Verano Announces First Quarter 2024 Financial Results
-
ACM Research Reports First Quarter 2024 Results
-
KANZHUN LIMITED to Report First Quarter 2024 Results on May 21, 2024

